RYVU THERAPEUTICS SA PLN0.40 financial statements, including revenue, expenses, profit, and loss

The total revenue of 0RKT for the last quarter is 15.07 M PLN, and it's 4.27% lower compared to the previous quarter. The net income of Q3 24 is -26.57 M PLN.